TCR Sequencing is increasingly being incorporated into clinical trials to better understand the role of T-cells in the efficacy of immunotherapies. By assessing the TCR repertoire before, during, and after treatment, researchers can identify biomarkers of response and resistance, ultimately guiding the development of more effective immunotherapeutic approaches.